NMR Studies of Retroviral Nucleic Acid Binding Proteins

逆转录病毒核酸结合蛋白的 NMR 研究

基本信息

项目摘要

DESCRIPTION (Provided by the applicant): During the past 3-1/2 years we (i) identified the stem loops of the HIV-1 Psi-RNA packaging signal that have high affinities for the nucleocapsid (NC) protein; (ii) determined the structures of NC complexes with HIV-1 Psi-site stem loops SL2 and SL3; (iii) established the functional roles of the HIV-1 CCHC zinc knuckles and their conserved amino acid residues; (iv) demonstrated that SL4 does not bind tightly to NC, as had previously been reported, and proposed a new role for this essential packaging element; and (v) discovered a novel three dimensional fold in the C-terminal zinc knuckle of the Mouse Mammary Tumor Virus (MMTV) NC protein. In addition, we recently (vi) developed a method for overproduction of the recombinant NC protein from the Moloney Murine Leukemia Virus (MLV), which is the most widely used vector in human gene therapy trials, and (vii) identified the minimal portion of MLV Psi-site that is necessary for high-affinity NC binding. Having completed studies of NC binding to isolated stem loops, we now intend to study NC interactions with the intact Psi-sites of MLV and HIV- 1. High quality preliminary NMR spectra have been obtained for the 102 nucleotide NC-binding domain of the MLV Psi-site (>70 percent assigned at the time of submission), and numerous intermolecular NOES have been observed in preliminary NMR data obtained for its complex with NC. Promising preliminary 3D NMR data have also been obtained for the intact, 116 nucleotide HIV-1 Psi- site, indicating that structural studies of this 72.4 kDa symmetrical dimer are also feasible. Studies of RNAs of 100 nucleotides or larger are technically more challenging than our previous studies with relatively small RNA stem loops. However, the potential payoff is substantially greater, and promises to provide the first detailed structural information for the recognition complexes that lead to the specific packaging of retroviral genomes. Such knowledge should not only facilitate the development of approaches for the treatment of AIDS and cancer, but should also assist in the development of MLV as a more effective agent for the therapeutic delivery of human genes.
描述(由申请人提供):在过去的3-1/2年中,我们(i)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL FINLEY SUMMERS其他文献

MICHAEL FINLEY SUMMERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL FINLEY SUMMERS', 18)}}的其他基金

Project 3 - Genome Recognition & Packaging
项目3-基因组识别
  • 批准号:
    10245116
  • 财政年份:
    2012
  • 资助金额:
    $ 31.68万
  • 项目类别:
The Center for HIV RNA Studies (CRNA)
HIV RNA 研究中心 (CRNA)
  • 批准号:
    8512187
  • 财政年份:
    2012
  • 资助金额:
    $ 31.68万
  • 项目类别:
Core 1 - NMR
核心 1 - 核磁共振
  • 批准号:
    10245108
  • 财政年份:
    2012
  • 资助金额:
    $ 31.68万
  • 项目类别:
RETROVIRUS RNA
逆转录病毒RNA
  • 批准号:
    8361085
  • 财政年份:
    2011
  • 资助金额:
    $ 31.68万
  • 项目类别:
RETROVIRUS RNA
逆转录病毒RNA
  • 批准号:
    8168561
  • 财政年份:
    2010
  • 资助金额:
    $ 31.68万
  • 项目类别:
NMR Studies of HIV-1 Proteins
HIV-1 蛋白的 NMR 研究
  • 批准号:
    7846578
  • 财政年份:
    2009
  • 资助金额:
    $ 31.68万
  • 项目类别:
HIV-RNA
艾滋病毒RNA
  • 批准号:
    7953793
  • 财政年份:
    2008
  • 资助金额:
    $ 31.68万
  • 项目类别:
HIV-RNA
艾滋病毒RNA
  • 批准号:
    7721165
  • 财政年份:
    2007
  • 资助金额:
    $ 31.68万
  • 项目类别:
Frontiers in Structural Biology
结构生物学前沿
  • 批准号:
    6748016
  • 财政年份:
    2004
  • 资助金额:
    $ 31.68万
  • 项目类别:
Expand Participation by Minorities in Biomedical Science
扩大少数族裔对生物医学科学的参与
  • 批准号:
    6863926
  • 财政年份:
    1996
  • 资助金额:
    $ 31.68万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 31.68万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 31.68万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 31.68万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 31.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 31.68万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 31.68万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 31.68万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 31.68万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 31.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 31.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了